GlassScriptPhysician profile
Vivek K Gupta
NPI 1881612133
$2,628.42
in general payments reported to CMS, 2019-2025
17 companies · $559 in 2025
The $559 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $106 · 2021: $41.16 · 2022: $595 · 2023: $668 · 2024: $349 · 2025: $559.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,477.16 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,510.58 | 2022-2025 | Inspire |
| Medtronic, INC. | $248.26 | 2021-2025 | Straightshot, Nim Vital |
| Optinose US, INC. | $139.61 | 2019-2025 | |
| Medtronic USA, INC. | $120.48 | 2019 | |
| Genzyme Corporation | $109.64 | 2023-2025 | |
| Stryker Corporation | $95.67 | 2019-2022 | |
| Acclarent, INC | $68.84 | 2020-2023 | Acclarent Balloon Inflation Device, Trudi Nav Cable |
| Intersect Ent, INC. | $57.58 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $50.46 | 2020-2021 | |
| Aerin Medical INC. | $47.96 | 2020-2024 | |
| Spirair, INC. | $40.03 | 2024 | Septalign |
| Glaxosmithkline, LLC. | $38.28 | 2024-2025 | Nucala |
| Livanova USA, INC. | $27.74 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Heron Therapeutics, INC. | $20.83 | 2022 | |
| Smith+Nephew, INC. | $18.91 | 2023 | Stravix |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $17.33 | 2023 | |
| Acera Surgical, INC. | $16.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.